Birth-control drug for mosquitoes to curb malaria
Washington: Using information about the unique mating practices of male Anopheles mosquitoes, which are deadly carriers of malaria and unlike other insects insert a plug to seal its sperm inside the female, scientists are zeroing in on a birth-control drug for them.
Richard H. G. Baxter from Yale University described the search for a new birth-control strategy for mosquitoes.
Anopheles gambiae mosquitoes mate in airborne swarms, but only females bite and feed on blood from people – the bite that transmits the malaria parasite to humans.
To ensure mating success, an Anopheles male produces a special “mating plug” to seal its sperm inside the female’s mating chamber.
For the study, the Yale researchers purified the specific enzyme, a transglutaminase, responsible for coagulating another protein called Plugin within the male’s seminal fluid to form the plug.
They went on to purify the Plugin protein and reconstitute the coagulation reaction in the lab, setting the stage to search for chemicals that inhibit this reaction.
The technology is based on a discovery about the plug in 2009 by Flaminia Catteruccia, then at Imperial College London.
Catteruccia’s research detailed the biochemical composition of the plug, identified the transglutaminase enzyme and showed that blocking the enzyme prevents females from storing sperm to fertilize their eggs. Catteruccia, now at the Harvard School of Public Health, is collaborating with Baxter and his team at Yale to translate that knowledge into technology to put a dent in the population of malaria mosquitoes.
“We have completed the necessary groundwork to start screening for chemicals that inhibit the enzyme,” Baxter said.
“I think that there’s a good chance that we will find a compound because there are many existing compounds that inhibit other transglutaminases. Ideally, it would be a substance that could be fed to males, sterilizing them so that they mate but no offspring result. It’s a well-established biological insect-control technology called the sterile insect technique and has been used for decades,” he said.
The sterile insect technique was first used to control the screwworm fly in the southern United States and other areas. The screwworm fly was once responsible for hundreds of millions of dollars in losses to the cattle industry and consumers.
The approach is used against tsetse flies in Africa that transmit sleeping sickness and can be effective against mosquitoes, which mate only once or twice in their lifetime. Male mosquitoes would be reared under controlled conditions, fed a transglutaminase inhibitor and released to mate with wild females, reducing the population without the use of insecticides.
The new approach may help to deploy the sterile insect technique against mosquitoes by overcoming previous logistical and environmental concerns.
“By developing a chemical that is specific to the Anopheles mosquito and applied in a contained environment, we can minimize both cost and environmental impact,” Baxter said.
The technology is compatible with other methods such as genetic modification, pioneered by the British firm Oxitec.
The sterile insect technique is a different approach than traditional malaria control strategies, such as the indoor spraying of insecticides and the use of insecticide-treated bed nets.
“Mosquitoes are adapting to the traditional control measures. They are becoming resistant to the commonly used insecticides such as DDT and pyrethroids, and they are avoiding bed nets by biting during the day and out-of-doors. The sterile insect technique moves us away from trying to deliver chemicals to female mosquitoes by spreading them around people. Instead, we feed a chemical to the male, and he finds the females for us,” Baxter added.
The findings of the study were presented at the 244th National Meeting and Exposition of the American Chemical Society.